Should You Buy Figs Inc (FIGS) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Hold
Latest Price
11.200
1 Day change
-0.80%
52 Week Range
12.500
Analysis Updated At
2026/01/28
Not a good buy right now for a beginner long-term investor who is unwilling to wait for a better entry. FIGS is sitting below its pivot with weakening momentum (bearish MACD), insiders are actively selling, and profitability trends are currently poor despite revenue growth. I would hold off and not deploy fresh capital at this price.
Technical Analysis
Price/levels: Closed at 11.35 (down -1.31%). This is below the pivot (11.589), which keeps the near-term bias cautious. Key levels: support S1=10.896 (then S2=10.468); resistance R1=12.283 (then R2=12.711).
Momentum: MACD histogram -0.13 and below 0 (bearish), though the negative momentum is contracting (selling pressure may be easing but trend is not yet bullish). RSI(6)=39 is weak/near oversold territory, consistent with a soft trend rather than a strong reversal.
Trend structure: Converging moving averages suggests a potential transition phase, but there is not yet confirmation of an uptrend.
**Intellectia Proprietary Trading Signals**
- [AI Stock Picker](module://ai_stock_pick): No signal on given stock today.
- [SwingMax](module://swingmax): No signal on given stock today.
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning vs flow: Open interest put/call ratio of 0.1 is very call-heavy (often interpreted as longer-running bullish positioning). However, the *daily volume* put/call ratio of 1.38 shows puts dominated trading flow on the observed day, which is more consistent with near-term caution/hedging.
Volatility: 30d IV ~58.6 vs HV ~60.8 (roughly in-line). IV percentile ~52 suggests options are not especially cheap or expensive versus the past year.
Takeaway: Sentiment is mixed—structural positioning looks bullish, but recent trading flow leans defensive.
Technical Summary
Sell
7
Buy
3
Positive Catalysts
Analyst narrative has improved after a strong Q3: multiple firms cited momentum, regional sales strength, higher margins, and growth initiatives (international expansion, TEAMS business, community hubs). Macro backdrop cited by Barclays (lower rates/gas) could be a tailwind for specialty retail. Pattern-based forward skew in the provided model is modestly positive (next month +3.24% probability-weighted expectation).
Neutral/Negative Catalysts
No fresh news catalysts in the past week. Insiders are selling and the selling amount increased 101.69% over the last month (a meaningful negative signal for near-to-mid-term confidence). Profitability deteriorated sharply YoY (net income and EPS down heavily), which can keep the stock range-bound and sensitive to any demand uncertainty. Some analysts flagged headwinds (e.g., tariffs next year) and Goldman still maintains a Sell rating (even after raising its target).
Financial Performance
Latest quarter: 2025/Q3. Revenue rose to $151.661M (+8.17% YoY), showing continued top-line growth. Gross margin improved to 69.94% (+4.29% YoY), which is constructive. However, net income fell to $8.746M (down -614.47% YoY) and EPS fell to $0.05 (down -600.00% YoY), signaling that earnings power is currently moving the wrong way despite better gross margins—likely driven by operating costs, investments, or other below-the-line pressures.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Price targets have been moving up notably since Q3, with several raises (BTIG up to $15 and reiterating Buy; Roth up to $12 with Buy; Barclays up to $11 with Equal Weight; Morgan Stanley up to $7.50 with Equal Weight; Telsey up to $9 with Market Perform). Goldman raised to $5.50 but kept Sell.
Wall Street pros: Improving business momentum post-Q3, margin improvement, and identifiable growth initiatives (international/TEAMS/community).
Wall Street cons: Demand uncertainty, potential tariff headwinds, and mixed conviction (multiple Equal Weight/Market Perform ratings plus at least one Sell). Net result: sentiment is improving but not decisively bullish.
Wall Street analysts forecast FIGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FIGS is 9.86 USD with a low forecast of 5.5 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
Wall Street analysts forecast FIGS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for FIGS is 9.86 USD with a low forecast of 5.5 USD and a high forecast of 15 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
5 Hold
2 Sell
Hold
Current: 11.290
Low
5.5
Averages
9.86
High
15
Current: 11.290
Low
5.5
Averages
9.86
High
15
Barclays
Equal Weight
maintain
$9 -> $11
AI Analysis
2026-01-06
Reason
Barclays
Price Target
$9 -> $11
AI Analysis
2026-01-06
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Figs to $11 from $9 and keeps an Equal Weight rating on the shares. The firm is "constructive" on the specialty retail sector into 2026, citing inventory discipline and macro tailwinds from lower interest rates and gas prices. However, stock selection "is critical as demand uncertainty persists," the analyst tells investors in a research note. Barclays adjusted price targets as part of its 2026 outlook.
BTIG
NULL -> Buy
upgrade
$12 -> $15
2025-12-10
Reason
BTIG
Price Target
$12 -> $15
2025-12-10
upgrade
NULL -> Buy
Reason
BTIG raised the firm's price target on Figs to $15 from $12 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FIGS
